neuroprotective compounds (Noscira)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameneuroprotective compounds (Noscira)
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNoscira Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNoscira Sa
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A